Long QT Syndrome News and Research

RSS
Long QT syndrome (LQTS) is a disease that affects the normal heart rhythm and electrical activity. It may lead to sudden onset and dangerous arrhythmias (irregularities of heart rate and rhythm) which may be brought on by triggers like exercise or stress.
Testing of hydroxychloroquine for COVID-19 begins at Montefiore And Einstein

Testing of hydroxychloroquine for COVID-19 begins at Montefiore And Einstein

Study reveals underlying mechanism for life-threatening cardiac arrhythmias

Study reveals underlying mechanism for life-threatening cardiac arrhythmias

Expert genomics panel disputes certain genes linked to a dangerous heart condition

Expert genomics panel disputes certain genes linked to a dangerous heart condition

ClinGen expert panel disputes nine genes linked to long QT syndrome

ClinGen expert panel disputes nine genes linked to long QT syndrome

Neuronal gene mutations may be linked to seizures associated with Long QT Syndrome

Neuronal gene mutations may be linked to seizures associated with Long QT Syndrome

Neuronal gene malfunction is behind seizures associated with long QT syndrome, study suggests

Neuronal gene malfunction is behind seizures associated with long QT syndrome, study suggests

Energy drinks may increase blood pressure and risk of electrical disturbances in heart

Energy drinks may increase blood pressure and risk of electrical disturbances in heart

Study confirms QT-prolonging effects of grapefruit juice

Study confirms QT-prolonging effects of grapefruit juice

New collaboration aims to prevent life-threatening adverse reactions to medications

New collaboration aims to prevent life-threatening adverse reactions to medications

WU biomedical engineer makes a significant step toward precision medicine

WU biomedical engineer makes a significant step toward precision medicine

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Scientists figure out way to measure fetal cardiac electrical activity

Scientists figure out way to measure fetal cardiac electrical activity

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

VTCRI scientist receives new federal grant for research into a heart mutation

VTCRI scientist receives new federal grant for research into a heart mutation

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

Combining stem cell technology and artificial intelligence to diagnose genetic cardiac diseases

Genomic science can help healthcare professionals to identify, treat inherited cardiac conditions

Genomic science can help healthcare professionals to identify, treat inherited cardiac conditions

Genetic heart mutations account for fewer sudden and unexplained infant deaths

Genetic heart mutations account for fewer sudden and unexplained infant deaths

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Energy drinks linked to risk of cardiac events in young people with familial long QT syndrome

Energy drinks linked to risk of cardiac events in young people with familial long QT syndrome